“…Future innovations in CI equipment manufacture are likely to depress purchase costs and encourage more widespread utilisation of this emerging technology in the pharmaceutical sector. Compositional information [28], [29] Quality assessment [20], [30] Process related information [31], [32] Blend uniformity [33], [34] Coating thickness [35] Counterfeit drug detection [36], [37] Remote identification [38], [41] Staring imager High throughput analysis [38], [39] [22], [49] Tablet characterisation [17], [29], [50], [51], [52], [53], […”